Genenta Science SPA

GNTA · NASDAQ

$0.63+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.63

Latest news

  • Press releaseGlobe Newswire

    Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University

  • Press releaseGlobe Newswire

    Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

  • NewsVandana Singh

    Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator

  • Press releaseGlobe Newswire

    Genenta Science Provides Update on CEO Ownership

  • Press releaseGlobe Newswire

    Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Gold Falls 3%; Carter's Shares Gain After Q3 Earnings

  • NewsAvi Kapoor

    Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results

  • Press releaseGlobe Newswire

    Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

  • NewsAvi Kapoor

    Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October

  • NewsAvi Kapoor

    Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings

  • NewsNabaparna Bhattacharya

    Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production

  • News

    Market-Moving News for October 24th

  • Press releaseGlobe Newswire

    Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

  • Press releaseGlobe Newswire

    Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

  • Press releasePRNewswire

    Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

  • Press releasePRNewswire

    TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

  • Press releasePRNewswire

    ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.